首頁 > 市場調查報告書 > 製藥

癌症生物製劑

市場調查報告書

商品編碼

1298705

癌症免疫療法市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Cancer Immunotherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年06月14日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2022年，全球癌症免疫治療市場規模達到1067億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到1820億美元，在2023-2028年期間，成長率（CAGR）為8.8%。癌症病例數量的成長、政府的有利計劃以及醫療保險的廣泛普及是推動市場發展的一些關鍵因素。

癌症是指一種疾病，身體中的一些細胞不受控制地生長，並擴散到身體的幾個部分。它是由飲酒或吸煙、不健康的飲食、空氣污染和不運動引起的。它可以導致嚴重的健康問題，如焦慮、抑鬱、對死亡的恐懼、疼痛、壓力和個人的自殺念頭。它可以通過免疫療法進行治療，免疫療法包括結合併抑制癌細胞所表達的蛋白質功能的抗體。癌症免疫療法有助於提高免疫系統，以檢測和摧毀個人中的異常癌細胞。除此之外，與其他治療方案相比，它引起的副作用更少，並減少了發生癌細胞的機率。因此，癌症免疫療法被廣泛用於治療全球個人的肺癌、乳腺癌、結腸直腸癌、黑色素瘤、前列腺、頭頸部、甲狀腺、腎臟、肝臟、宮頸、膀胱、卵巢和皮膚癌。

癌症免疫療法市場趨勢和驅動因素：

目前，由於世界各地的人飲食不均衡和食用有毒物質，導致癌症病例不斷增加，這是積極影響市場的主要因素之一。此外，全球群眾對各種癌症治療方案的認知不斷提高，也促進了市場的成長。除此之外，癌症免疫療法的使用越來越多，因為與抗腫瘤療法相比，它們提供了更長的無進展生存期（PFS）和總生存期（OS），正在提供一個積極的市場前景。此外，醫療保險的廣泛提供和容易獲得，以及醫療支出的增加，正在為行業投資者提供有利可圖的成長機會。此外，世界各地的群眾對副作用較少的治療方案的需求也在增加。這一點，再加上由於新型免疫療法獲得越來越多的批准而擴大採用癌症免疫療法，正在促進市場的成長。與此相呼應，各國的管理機構和非營利組織正在鼓勵採用癌症免疫療法，在全球範圍內傳播預防癌症的意識，這推動了市場的成長。此外，癌症治療療法的各種技術進步，有效地治療疾病，正在加強市場的成長。

本報告中回答的關鍵問題：

迄今為止，全球癌症免疫治療市場的表現如何，在未來幾年內將如何表現？
全球癌症免疫療法市場的驅動因素、限制因素和機會是什麼？
每個驅動因素、限制因素和機會對全球癌症免疫治療市場的影響是什麼？
主要的區域市場是什麼？
哪些國家代表了最具吸引力的癌症免疫治療市場？
基於治療類型的市場細分是什麼？
癌症免疫治療市場中最有吸引力的治療類型是什麼？
基於應用的市場細分是什麼？
癌症免疫治療市場中最有吸引力的應用是什麼？
基於終端用戶的市場細分是什麼？
哪個是癌症免疫治療市場中最有吸引力的終端用戶？
全球癌症免疫治療市場的競爭結構是什麼？
誰是全球癌症免疫療法市場的主要參與者/公司？

北美洲
- 美國
  - 市場趨勢
  - 市場預測
- 加拿大
  - 市場趨勢
  - 市場預測
亞太地區
- 中國
  - 市場趨勢
  - 市場預測
- 日本
  - 市場趨勢
  - 市場預測
- 印度
  - 市場趨勢
  - 市場預測
- 韓國
  - 市場趨勢
  - 市場預測
- 澳大利亞
  - 市場趨勢
  - 市場預測
- 印尼
  - 市場趨勢
  - 市場預測
- 其他國家
  - 市場趨勢
  - 市場預測
歐洲
- 德國
  - 市場趨勢
  - 市場預測
- 法國
  - 市場趨勢
  - 市場預測
- 英國
  - 市場趨勢
  - 市場預測
- 義大利
  - 市場趨勢
  - 市場預測
- 西班牙
  - 市場趨勢
  - 市場預測
- 俄羅斯
  - 市場趨勢
  - 市場預測
- 其他國家
  - 市場趨勢
  - 市場預測
拉丁美洲
- 巴西
  - 市場趨勢
  - 市場預測
- 墨西哥
  - 市場趨勢
  - 市場預測
- 其他國家
  - 市場趨勢
  - 市場預測
中東和非洲
- 市場趨勢
- 按國家分類的市場
- 市場預測

第十章：SWOT分析

概述
優勢
劣勢
機會
威脅

第十一章：價值鏈分析

第十二章：波特五力分析

概述
買方的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第十三章：價格分析

第十四章：競爭格局

市場結構
主要參與者
主要參與者的概況
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck KGAA
- Novartis AG
- Pfizer Inc.
- Sanofi
- Seagen Inc.

簡介目錄圖表

Product Code: SR112023A5095

The global cancer immunotherapy market size reached US$ 106.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 182.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028. The growing number of cancer cases, favorable government initiatives, and wide availability of medical insurance represent some of the key factors driving the market.

Cancer refers to a disease wherein some of the cells in the body grow uncontrollably and spread across several body parts. It is caused by alcohol or tobacco consumption, an unhealthy diet, air pollution, and physical inactivity. It can lead to severe health problems, such as anxiety, depression, fear of death, pain, stress, and suicidal thoughts among individuals. It can be treated through immunotherapy, which comprises antibodies that bind, and inhibit the function of proteins expressed by cancer cells. Cancer immunotherapy assists in boosting the immune system to detect and destroy abnormal cancer cells among individuals. Besides this, it causes fewer side effects as compared to other treatment options and reduces the chances of occurring cancerous cells. As a result, cancer immunotherapy is widely utilized to treat lung, breast, colorectal, melanoma, prostate, head and neck, thyroid, kidney, liver, cervical, bladder, ovarian, and skin cancers among individuals across the globe.

Cancer Immunotherapy Market Trends and Drivers:

At present, the increasing number of cancer cases due to the poor balanced diet and consumption of toxic substances among individuals around the world represents one of the major factors influencing the market positively. In addition, the rising awareness about various cancer treatment options among the masses across the globe is contributing to the market growth. Apart from this, the growing utilization of cancer immunotherapies, as they provide prolonged progression-free survival (PFS) and overall survival (OS) compared to anti-tumor therapies, is offering a positive market outlook. Moreover, the wide availability and easy access to medical insurance, along with the increasing healthcare expenditure, is offering lucrative growth opportunities to industry investors. In addition, there is a rise in the demand for treatment solutions with fewer side effects among the masses around the world. This, coupled with the growing adoption of cancer immunotherapies due to the increasing approval for novel immunotherapies, is bolstering the growth of the market. In line with this, governing agencies and non-profit organizations of various countries are encouraging the adoption of cancer immunotherapy by spreading awareness about cancer prevention worldwide is impelling the growth of the market. Furthermore, various technological advancements in cancer treatment therapies to efficiently treat the disease are strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer immunotherapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapy type, application and end user.

Therapy Type Insights:

Monoclonal Antibodies

Cancer Vaccines

Checkpoint Inhibitors

Immunomodulators

Others

The report has provided a detailed breakup and analysis of the cancer immunotherapy market based on the therapy type. This includes monoclonal antibodies, cancer vaccines, checkpoint inhibitors, immunomodulators, and others. According to the report, monoclonal antibodies represented the largest segment.

Application Insights:

Lung Cancer

Breast Cancer

Colorectal Cancer

Melanoma

Prostate Cancer

Head and Neck Cancer

Others

A detailed breakup and analysis of the cancer immunotherapy market based on the application has also been provided in the report. This includes lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head and neck cancer, and others. According to the report, lung cancer accounted for the largest market share.

End User Insights:

Hospitals

Cancer Research Centers

Clinics

Others

A detailed breakup and analysis of the cancer immunotherapy market based on the end user has also been provided in the report. This includes hospitals, cancer research centers, clinics, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for cancer immunotherapy. Some of the factors driving the North America cancer immunotherapy market included the growing number of patients suffering from cancer, rising development of bioinformatic tools, favorable government initiatives, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cancer immunotherapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck KGAA, Novartis AG, Pfizer Inc., Sanofi, Seagen Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

Key Questions Answered in This Report:

How has the global cancer immunotherapy market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global cancer immunotherapy market?
What is the impact of each driver, restraint, and opportunity on the global cancer immunotherapy market?
What are the key regional markets?
Which countries represent the most attractive cancer immunotherapy market?
What is the breakup of the market based on the therapy type?
Which is the most attractive therapy type in the cancer immunotherapy market?
What is the breakup of the market based on the application?
Which is the most attractive application in the cancer immunotherapy market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the cancer immunotherapy market?
What is the competitive structure of the global cancer immunotherapy market?
Who are the key players/companies in the global cancer immunotherapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cancer Immunotherapy Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Therapy Type

6.1 Monoclonal Antibodies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Cancer Vaccines
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Checkpoint Inhibitors
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Immunomodulators
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Lung Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Breast Cancer
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Colorectal Cancer
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Melanoma
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Prostate Cancer
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Head and Neck Cancer
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cancer Research Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Amgen Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 AstraZeneca plc
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bayer AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Bristol-Myers Squibb Company
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Eli Lilly and Company
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 F. Hoffmann-La Roche AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 SWOT Analysis
- 14.3.7 GlaxoSmithKline Plc
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Johnson & Johnson
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Merck KGAA
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Novartis AG
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Pfizer Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Sanofi
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis
- 14.3.13 Seagen Inc.
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Cancer Immunotherapy Market: Major Drivers and Challenges
Figure 2: Global: Cancer Immunotherapy Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Immunotherapy Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Immunotherapy Market: Breakup by Therapy Type (in %), 2022
Figure 5: Global: Cancer Immunotherapy Market: Breakup by Application (in %), 2022
Figure 6: Global: Cancer Immunotherapy Market: Breakup by End User (in %), 2022
Figure 7: Global: Cancer Immunotherapy Market: Breakup by Region (in %), 2022
Figure 8: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cancer Immunotherapy (Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Immunotherapy (Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Immunotherapy (Immunomodulators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Immunotherapy (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Immunotherapy (Other Therapy Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Immunotherapy (Other Therapy Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Immunotherapy (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Immunotherapy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Immunotherapy (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Immunotherapy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Immunotherapy (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Immunotherapy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Immunotherapy (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Immunotherapy (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cancer Immunotherapy (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cancer Immunotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cancer Immunotherapy (Head and Neck Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cancer Immunotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cancer Immunotherapy (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cancer Immunotherapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cancer Immunotherapy (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cancer Immunotherapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Cancer Immunotherapy (Cancer Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Cancer Immunotherapy (Cancer Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Cancer Immunotherapy (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Cancer Immunotherapy (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Cancer Immunotherapy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Cancer Immunotherapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Cancer Immunotherapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Cancer Immunotherapy Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Cancer Immunotherapy Industry: SWOT Analysis
Figure 90: Global: Cancer Immunotherapy Industry: Value Chain Analysis
Figure 91: Global: Cancer Immunotherapy Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Immunotherapy Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Immunotherapy Market Forecast: Breakup by Therapy Type (in Million US$), 2023-2028
Table 3: Global: Cancer Immunotherapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Cancer Immunotherapy Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Cancer Immunotherapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cancer Immunotherapy Market: Competitive Structure
Table 7: Global: Cancer Immunotherapy Market: Key Players

02-2729-4219

+886-2-2729-4219